Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Further evidence for the association of GAL , GALR1 and NPY1R variants with Opioid Dependence

Pharmacogenomics(2020)10.2217/pgs-2020-0045Source: DataRank Database

Further evidence for the association of GAL , GALR1 and NPY1R variants with Opioid Dependence is a research paper published in Pharmacogenomics (2020). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

refsnp doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.09)OA: greenTopics (63)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Orna Levran ORCID,Wim van den Brink ORCID,Peter Blanken ORCID,Jan M. van Ree,Jürg Ott ORCID

Live enrichment

PubMed:32757697 PMC:PMC7487975 OpenAlex:https://openalex.org/W3048061804

National Institutes of Health

Grant: R01-DA012848

NIDA NIH HHS

Grant: R01 DA012848

National Institutes of Health

Grant: 3R01DA012848-05S1

ADDICTIONS: GENOTYPES, POLYMOPHISMS, AND FUNCTION

Netherlands Ministry of Health

Dr Miriam & Sheldon G. Adelson Medical Research

FWCI

0.09

Citation Percentile

0.4%

Citation Trend

2021

2024

2025

green

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7487975

publisherhttps://www.tandfonline.com/doi/pdf/10.2217/pgs-2020-0045

journalhttps://doi.org/10.2217/pgs-2020-0045

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32757697

Fields of Study

Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and OutcomesEpigenetics and DNA Methylation0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AdultHeroinFemaleGenotypeHaplotypesHeroin DependenceHumansMaleMethadoneOpioid-Related DisordersCase-Control StudiesReceptors, Neuropeptide YGenetic Predisposition to DiseasePolymorphism, Single NucleotideReceptor, Galanin, Type 1Opiate Substitution Treatment

Keywords

HeroinSNPOpioidSingle-nucleotide polymorphismAddictionGenetic associationMethadone maintenanceInternal medicineMethadoneAssociation (psychology)Heroin addictionMedicineGenePsychiatryClinical psychologyPharmacologyGeneticsPsychologyDrugBiologyGenotypeReceptorPsychotherapistOpioid DependenceGalGalr1Npy1rCase–control Association StudyAdultMaleHeroin DependenceOpioid-Related DisordersPolymorphism, Single NucleotideReceptor, Galanin, Type 1Receptors, Neuropeptide YHaplotypesCase-Control StudiesOpiate Substitution TreatmentHumansFemaleGenetic Predisposition to Disease

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Further evidence for the association of GAL , GALR1 and NPY1R variants with Opioid Dependence

FAIR Checklist

Authors (7)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)